Mizuho Analyst Maintains Buy Rating on Arcus Biosciences with Lowered Price Target
On January 30, 2024, Mara Goldstein, an analyst at Mizuho, expressed her positive outlook on Arcus Biosciences (NYSE:RCUS) by maintaining ...
© 2024 Stocks Today
Tag: RCUS
Popular News
-
Exploring the Rise of AI in Empowering Business and Personal Growth: Trends and Innovations
-
Unlocking the Future: The Rise of Open-Source FPGA Development Tools
-
The Future of Secure Communications: How Quantum-Resistant Encryption is Revolutionizing Wireless Technology
-
The Booming Market of Plant-Based Pharmaceuticals for Neurological Conditions
-
Unlocking Potential: How Recent Acquisitions in the Battery Technology Sector Are Reshaping the Energy Landscape